N. Abdul-Aziz, N. Abdulhameed, A. Marellapudi, and H. Shah, “Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia”, Translation, vol. 11, no. 3, Dec. 2023.